Participation of transmembrane proline 82 in angiotensin II AT1 receptor signal transduction

被引:13
作者
Reis, Rosana I.
Santos, Edson L.
Pesquero, Joao B.
Oliveira, Laerte
Schanstra, Joost P.
Bascands, Jean-Loup
Pecher, Christiane
Paiva, Antonio C. M.
Costa-Neto, Claudio M. [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 Sao Paulo, Brazil
[3] INSERM, U388, F-31432 Toulouse, France
[4] Univ Toulouse 3, Inst Louis Bugnard, IFR31, F-31432 Toulouse, France
基金
巴西圣保罗研究基金会;
关键词
site-directed mutagenesis; signal transduction; G-protein coupled receptors; agonist;
D O I
10.1016/j.regpep.2006.11.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most of the classical physiological effects of the octapeptide angiotensin II (AngII) are produced by activating the AT, receptor which belongs to the G-protein coupled receptor family (GPCR). Peptidic GPCRs may be functionally divided in three regions: (i) extracellular domains involved in ligand binding; (ii) intracellular domains implicated in agonist-induced coupling to G protein and (iii) seven transmembrane domains (TM) involved in signal transduction. The TM regions of such receptors have peculiar characteristics such as the presence of proline residues. In this project we aimed to investigate the participation of two highly conserved proline residues (Pro82 and Pro162), located in TM II and TM IV, respectively, in AT1 receptor signal transduction. Both mutations did not cause major alterations in AngII affinity. Functional assays indicated that the P162A mutant did not influence the signal transduction. On the other hand, a potent deleterious effect of P82A mutation on signal transduction was observed. We believe that the Pro82 residue is crucial to signal transduction, although it is not possible to say yet if this is due to a direct participation or if due to a structural rearrangement of TM II. In this last hypothesis, the removal of proline residue might be correlated to a removal of a kink, which in turn can be involved in the correct positioning of residues involved in signal transduction. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 17 条
[1]   Angiotensin peptides and inducible transcription factors [J].
Blume, A ;
Herdegen, T ;
Unger, T .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (03) :339-357
[2]   Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket [J].
Boucard, AA ;
Roy, M ;
Beaulieu, ME ;
Lavigne, P ;
Escher, E ;
Guillemette, G ;
Leduc, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36628-36636
[3]   Aliphatic amino acids in helix VI of the AT1 receptor play a relevant role in agonist binding and activity [J].
Correa, SAA ;
Zalcberg, H ;
Han, SW ;
Oliveira, L ;
Costa-Neto, CM ;
Paiva, ACM ;
Shimuta, SI .
REGULATORY PEPTIDES, 2002, 106 (1-3) :33-38
[4]   Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT1A receptor [J].
Costa-Neto, CM ;
Mikakawa, AA ;
Oliveira, L ;
Hjorth, SA ;
Schwartz, TW ;
Paiva, ACM .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (06) :1263-1268
[5]   THE DOCKING OF ARG(2) OF ANGIOTENSIN-II WITH ASP(2) RECEPTOR IS ESSENTIAL FOR FULL AGONISM [J].
FENG, YH ;
NODA, K ;
SAAD, Y ;
LIU, XP ;
HUSAIN, A ;
KARNIK, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12846-12850
[6]   Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction [J].
Han, HMCB ;
Shimuta, SI ;
Kanashiro, CA ;
Oliveira, L ;
Han, SW ;
Paiva, ACM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (06) :810-814
[7]  
HJORTH SA, 1994, J BIOL CHEM, V269, P30953
[8]   Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix [J].
Hunyady, L ;
Ji, H ;
Jagadeesh, G ;
Zhang, M ;
Gáborik, Z ;
Mihalik, B ;
Catt, KJ .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :427-434
[9]   Angiotensin receptors: Molecular biology and signalling [J].
Inagami, T ;
Kambayashi, Y ;
Ichiki, T ;
Tsuzuki, S ;
Eguchi, S ;
Yamakawa, T .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) :544-549
[10]   A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism [J].
Inoue, Y ;
Nakamura, N ;
Inagami, T .
JOURNAL OF HYPERTENSION, 1997, 15 (07) :703-714